Alzheimer's disease targeted nano-based drug delivery systems
G Altinoglu, T Adali - Current Drug Targets, 2020 - ingentaconnect.com
Alzheimer's disease (AD) is the most common neurodegenerative disease, and is part of a
massive and growing health care burden that is destroying the cognitive function of more …
massive and growing health care burden that is destroying the cognitive function of more …
Nanoparticles for the potential treatment of Alzheimer's disease: A physiopathological approach
N Navarro Martínez, J Toledo Hernández… - Nanotechnology …, 2023 - degruyter.com
Alzheimer's disease (AD) is a multifactorial neurodegenerative central system disease with a
high prevalence among the elderly and is the most common form of dementia. Oxidative …
high prevalence among the elderly and is the most common form of dementia. Oxidative …
Treating Alzheimer's disease using nanoparticle-mediated drug delivery strategies/systems
AK Roghani, RI Garcia, A Roghani, A Reddy… - Ageing Research …, 2024 - Elsevier
The administration of promising medications for the treatment of neurodegenerative
disorders (NDDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's …
disorders (NDDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's …
Neurotherapeutic applications of nanoparticles in Alzheimer's disease
A rapid increase in incidence of neurodegenerative disorders has been observed with the
aging of the population. Alzheimer's disease (AD) is the most common neurodegenerative …
aging of the population. Alzheimer's disease (AD) is the most common neurodegenerative …
Multifunctional nanocarriers for Alzheimer's disease: befriending the barriers
MA Ansari, T Tripathi, B Venkidasamy, A Monziani… - Molecular …, 2024 - Springer
Neurodegenerative diseases (NDDs) have been increasing in incidence in recent years and
are now widespread worldwide. Neuronal death is defined as the progressive loss of …
are now widespread worldwide. Neuronal death is defined as the progressive loss of …
[HTML][HTML] Advances in developing therapeutic strategies for Alzheimer's disease
Alzheimer's disease (AD) is a progressive deterioration of brain function, initially
characterized by cognitive deficits, with loss of recent memory and language ability …
characterized by cognitive deficits, with loss of recent memory and language ability …
Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics
Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disorder
manifested by memory loss and cognitive impairment. Deposition of the amyloid β plaques …
manifested by memory loss and cognitive impairment. Deposition of the amyloid β plaques …
Recent advances in the treatment of Alzheimer's disease using nanoparticle-based drug delivery systems
P Poudel, S Park - Pharmaceutics, 2022 - mdpi.com
Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disorder.
Most existing treatments only provide symptomatic solutions. Here, we introduce currently …
Most existing treatments only provide symptomatic solutions. Here, we introduce currently …
Nanomedicine in the management of Alzheimer's disease: State-of-the-art
SN Mir Najib Ullah, O Afzal, ASA Altamimi, H Ather… - Biomedicines, 2023 - mdpi.com
Alzheimer's disease (AD) is a deadly, progressive, and irreversible brain condition that
impairs cognitive abilities. Globally, it affects 32.6 million individuals, and if no viable …
impairs cognitive abilities. Globally, it affects 32.6 million individuals, and if no viable …
Advancements in nanotherapeutics for Alzheimer's disease: current perspectives
Objectives Considerable progress has been made in the treatment of Alzheimer's disease
(AD), but all available strategies focus on alleviating symptoms rather than curing, which …
(AD), but all available strategies focus on alleviating symptoms rather than curing, which …